Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 109,878,608
  • Shares Outstanding, K 1,482,442
  • Annual Sales, $ 20,074 M
  • Annual Income, $ 2,898 M
  • EBIT $ 4,510 M
  • EBITDA $ 6,165 M
  • 60-Month Beta 0.67
  • Price/Sales 5.63
  • Price/Cash Flow 20.67
  • Price/Book 4.78

Options Overview Details

View History
  • Implied Volatility 28.52% (-1.19%)
  • Historical Volatility 60.11%
  • IV Percentile 68%
  • IV Rank 31.54%
  • IV High 52.68% on 04/04/25
  • IV Low 17.38% on 07/29/25
  • Expected Move (DTE 2) 1.79 (2.42%)
  • Put/Call Vol Ratio 0.18
  • Today's Volume 30,833
  • Volume Avg (30-Day) 39,547
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 450,322
  • Open Int (30-Day) 345,630
  • Expected Range 72.46 to 76.04

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 31 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.79
  • Number of Estimates 8
  • High Estimate 0.80
  • Low Estimate 0.78
  • Prior Year 0.75
  • Growth Rate Est. (year over year) +5.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.92 +0.45%
on 02/10/26
97.90 -24.16%
on 01/12/26
-23.39 (-23.96%)
since 01/09/26
3-Month
73.92 +0.45%
on 02/10/26
105.65 -29.72%
on 11/13/25
-26.66 (-26.42%)
since 11/10/25
52-Week
73.92 +0.45%
on 02/10/26
109.50 -32.19%
on 09/09/25
-31.93 (-30.07%)
since 02/10/25

Most Recent Stories

More News
Levi & Korsinsky Investigates Possible Securities Fraud by Boston Scientific Corporation (BSX)

New York, New York--(Newsfile Corp. - February 10, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation (NYSE: BSX) ("Boston Scientific...

BSX : 74.25 (+0.18%)
Securities Fraud Investigation Into Boston Scientific Corporation (BSX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Boston Scientific Corporation (“Boston Scientific”...

BSX : 74.25 (+0.18%)
Fraud Investigation Opened: Levi & Korsinsky Investigates Boston Scientific Corporation (BSX) on Behalf of Shareholders

New York, New York--(Newsfile Corp. - February 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation")...

BSX : 74.25 (+0.18%)
3 Safe-and-Steady Stocks to Consider Right Now

3 Safe-and-Steady Stocks to Consider Right Now

BR : 172.51 (-4.72%)
INTU : 421.39 (-3.68%)
BSX : 74.25 (+0.18%)
Boston Scientific Corporation (BSX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith announces an investigation on behalf of Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX ) investors concerning the...

BSX : 74.25 (+0.18%)
Securities Fraud Investigation Into Boston Scientific Corporation (BSX) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz announces an investigation of Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX ) on behalf of investors concerning...

BSX : 74.25 (+0.18%)
Investors in Boston Scientific Corporation (BSX) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today

New York, New York--(Newsfile Corp. - February 5, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation")...

BSX : 74.25 (+0.18%)
Don't Miss Out: Strangle Plays on These 3 Top 25 Unusually Active Options Gems!

There were 1,234 unusually active options on Wednesday. Among the top 25 Vol/OI ratios were three popular stocks: Peloton Interactive, Boston Scientific, and Uber Technologies. There’s an argument for...

MSTR : 133.00 (-3.93%)
BSX : 74.25 (+0.18%)
PTON : 4.35 (-1.14%)
AMD : 213.57 (-1.12%)
UBER : 73.50 (-0.55%)
Stocks Slip Before the Open as Tech-Led Selloff Continues, Amazon Earnings on Tap

March S&P 500 E-Mini futures (ESH26) are down -0.42%, and March Nasdaq 100 E-Mini futures (NQH26) are down -0.55% this morning, pointing to further losses on Wall Street as technology stocks face renewed...

GOOGL : 318.58 (-1.77%)
NVDA : 188.54 (-0.79%)
AVGO : 340.44 (-1.02%)
BNP.FP : 93.250 (+0.24%)
COP : 107.50 (-1.10%)
SHEL.LN : 2,858.500 (+0.94%)
BSX : 74.25 (+0.18%)
SMCI : 33.33 (-0.60%)
ALGN : 196.27 (+1.96%)
ESH26 : 6,971.75 (+0.15%)
BMY : 60.86 (+0.15%)
TSLA : 425.21 (+1.89%)
BSX Q4 Deep Dive: Growth Engines Face Scrutiny as Market Reacts to Guidance and Segment Dynamics

BSX Q4 Deep Dive: Growth Engines Face Scrutiny as Market Reacts to Guidance and Segment Dynamics

BSX : 74.25 (+0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is below 30%. The market is in oversold territory. Watch for a potential trend reversal.

See More Share

Business Summary

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and...

See More

Key Turning Points

3rd Resistance Point 76.64
2nd Resistance Point 76.03
1st Resistance Point 75.14
Last Price 74.25
1st Support Level 73.64
2nd Support Level 73.03
3rd Support Level 72.14

See More

52-Week High 109.50
Fibonacci 61.8% 95.91
Fibonacci 50% 91.71
Fibonacci 38.2% 87.51
Last Price 74.25
52-Week Low 73.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar